You are here

Microfluidic Analytical Separator for Proteomics

Award Information
Agency: National Aeronautics and Space Administration
Branch: N/A
Contract: NNJ05JA05C
Agency Tracking Number: 033429
Amount: $599,947.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: B2.03
Solicitation Number: N/A
Timeline
Solicitation Year: 2003
Award Year: 2005
Award Start Date (Proposal Award Date): 2004-11-22
Award End Date (Contract End Date): 2006-11-21
Small Business Information
7200 Highway 150
GREENVILLE, IN 47124-9515
United States
DUNS: 621970383
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Paul Todd
 Principal Investigator
 (812) 923-9591
 ptodd@SHOT.com
Business Contact
 Mark Deuser
Title: Business Official
Phone: (812) 923-9591
Email: mdeuser@SHOT.com
Research Institution
N/A
Abstract

The proposed innovation is a microfluidic device designed to effect a 2-dimensional resolution of a mixture of proteins based on isoelectric point (pI) and molecular weight (MW). The innovation performs tasks similar to those performed by 2-dimensional ("2-D") gel electrophoresis. To achieve 2-D-gel equivalence with minimal complications and maximum exploitation of the advantages provided by microfluidics a novel approach is proposed. In this approach the user dissolves or mixes a sample to be tested for proteins into a sample buffer and injects this into a plastic card consisting of microfluidic channels and electrodes. The card is inserted into a compact "reader" (small enough for space flight) that, within four hours, electronically reports the abundance of each protein detected. In Phase II research SHOT will (1) establish fabrication parameters for the card and manufacture prototypes, (2) build a breadboard reader and (3) test the Microfluidic Analytical Separator using mixed protein solutions. The innovation is useful in detecting specific protein ratio changes in blood or plasma, in extracts of experimental organisms subjected to varying environmental conditions, and in the medium-resolution high-throughput screening of pharmaceutical agents.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government